<VariationArchive VariationID="830947" VariationName="NC_000010.11:g.(?_89228180)_(89228418_?)del" VariationType="Deletion" Accession="VCV000830947" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="820278" VariationID="830947">
      <GeneList>
        <Gene Symbol="LIPA" FullName="lipase A, lysosomal acid type" GeneID="3988" HGNC_ID="HGNC:6617" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q23.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="89213572" stop="89251775" display_start="89213572" display_stop="89251775" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="90973325" stop="91011659" display_start="90973325" display_stop="91011659" Strand="-" />
          </Location>
          <OMIM>613497</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000010.11:g.(?_89228180)_(89228418_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>10q23.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" innerStart="90987937" innerStop="90988175" display_start="90987937" display_stop="90988175" variantLength="239" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.(?_90987937)_(90988175_?)del" Assembly="GRCh37">
            <Expression>NC_000010.10:g.(?_90987937)_(90988175_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000010.11:g.(?_89228180)_(89228418_?)del AND Lysosomal acid lipase deficiency" Accession="RCV001031544" Version="2">
        <ClassifiedConditionList TraitSetID="41">
          <ClassifiedCondition DB="MedGen" ID="C5574740">Lysosomal acid lipase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-09-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-09-16" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26350820</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="41" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2626" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Acid cholesteryl ester hydrolase deficiency, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Lysosomal acid lipase deficiency</ElementValue>
                <XRef ID="Wolman+disease/7523" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010204" DB="MONDO" />
                <XRef ID="MONDO:0800449" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12097" />
                <XRef ID="12097" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of lysosomal acid lipase (LAL) deficiency ranges from the infantile-onset form (Wolman disease) to later-onset forms collectively known as cholesterol ester storage disease (CESD). Wolman disease is characterized by infantile-onset malabsorption that results in malnutrition, storage of cholesterol esters and triglycerides in hepatic macrophages that results in hepatomegaly and liver disease, and adrenal gland calcification that results in adrenal cortical insufficiency. Unless successfully treated with hematopoietic stem cell transplantation (HSCT), infants with classic Wolman disease do not survive beyond age one year. CESD may present in childhood in a manner similar to Wolman disease or later in life with such findings as serum lipid abnormalities, hepatosplenomegaly, and/or elevated liver enzymes long before a diagnosis is made. The morbidity of late-onset CESD results from atherosclerosis (coronary artery disease, stroke), liver disease (e.g., altered liver function Â± jaundice, steatosis, fibrosis, cirrhosis and related complications of esophageal varices, and/or liver failure), complications of secondary hypersplenism (i.e., anemia and/or thrombocytopenia), and/or malabsorption. Individuals with CESD may have a normal life span depending on the severity of disease manifestations.</Attribute>
                <XRef ID="NBK305870" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="Suggested Reading" Abbrev="Shirley, 2015">
                <ID Source="PubMed">26452566</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">26225414</ID>
                <ID Source="BookShelf">NBK305870</ID>
              </Citation>
              <XRef ID="275761" DB="Orphanet" />
              <XRef ID="C5574740" DB="MedGen" />
              <XRef ID="MONDO:0800449" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS278000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2356104" SubmissionDate="2020-02-06" DateLastUpdated="2020-04-15" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4137149|MedGen:C0043208" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194850" DateUpdated="2020-04-15" DateCreated="2020-04-15" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26350820</ID>
          </Citation>
          <Comment>This variant is an out-of-frame deletion of the genomic region encompassing exon 4 of the LIPA gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product. This variant has been observed to segregate with lysosomal acid lipase (LAL) deficiency in a family (PMID: 26350820). Loss-of-function variants in LIPA are known to be pathogenic (PMID: 23485521). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LIPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.(?_90987937)_(90988175_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Lysosomal acid lipase deficiency</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0043208" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2356104" TraitType="Disease" MappingType="Name" MappingValue="Lysosomal acid lipase deficiency" MappingRef="Preferred">
        <MedGen CUI="C5574740" Name="Lysosomal acid lipase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

